Whit Mayo
Stock Analyst at Wells Fargo
(4.15)
# 462
Out of 4,757 analysts
203
Total ratings
54.92%
Success rate
11.09%
Average return
Main Sectors:
Stocks Rated by Whit Mayo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BK The Bank of New York Mellon Corporation | Maintains: Equal-Weight | $86 → $96 | $86.56 | +10.91% | 7 | Mar 3, 2025 | |
| AHCO AdaptHealth | Maintains: Buy | $12 → $11 | $10.44 | +5.36% | 11 | Feb 13, 2025 | |
| EHAB Enhabit | Reiterates: Market Perform | $8.5 → $8 | $8.54 | -6.32% | 2 | Nov 19, 2024 | |
| RF Regions Financial | Maintains: Equal-Weight | $24 → $28 | $22.09 | +26.75% | 5 | Nov 15, 2024 | |
| PNC The PNC Financial Services Group | Maintains: Overweight | $215 → $235 | $180.47 | +30.22% | 5 | Nov 15, 2024 | |
| FITB Fifth Third Bancorp | Maintains: Overweight | $52 → $54 | $40.45 | +33.50% | 4 | Nov 15, 2024 | |
| BAC Bank of America | Maintains: Overweight | $52 → $56 | $42.29 | +32.42% | 4 | Nov 15, 2024 | |
| MS Morgan Stanley | Upgrades: Equal-Weight | $107 → $142 | $123.75 | +14.75% | 5 | Nov 15, 2024 | |
| ARDT Ardent Health Partners | Maintains: Outperform | $23 → $25 | $15.32 | +63.19% | 2 | Nov 12, 2024 | |
| HUM Humana | Downgrades: Market Perform | $400 → $250 | $262.12 | -4.62% | 12 | Oct 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $100 | $100.00 | - | 1 | Jul 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $5 | $4.02 | +24.38% | 4 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $15 | $18.39 | -18.43% | 1 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $45 → $52 | $59.38 | -12.43% | 2 | Dec 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $60 → $55 | $72.96 | -24.62% | 3 | Aug 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $625 → $560 | $475.98 | +17.65% | 11 | Jun 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $177.72 | - | 11 | May 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $50 → $38 | $51.28 | -25.90% | 1 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $420 → $390 | $593.07 | -34.24% | 1 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $98 → $97 | $92.54 | +4.82% | 1 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $165 → $155 | $178.20 | -13.02% | 1 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $21 → $20 | $16.26 | +23.00% | 1 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $309 → $335 | $309.83 | +8.12% | 5 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $580 | $397.47 | +45.92% | 3 | Jan 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $96 → $85 | $92.03 | -7.64% | 16 | Jan 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $238 → $286 | $319.63 | -10.52% | 17 | Dec 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $55 → $40 | $23.97 | +66.88% | 7 | Nov 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $46 → $39 | $25.69 | +51.81% | 7 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $3 → $1.5 | $3.83 | -60.84% | 4 | Nov 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $33 → $30 | $3.54 | +747.46% | 5 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $20 → $16 | $14.59 | +9.66% | 10 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $89 → $55 | $126.02 | -56.36% | 14 | Oct 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $95 → $103 | $29.68 | +247.04% | 10 | Aug 26, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $235 → $175 | $116.31 | +50.46% | 1 | Apr 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $19 | $15.81 | +20.18% | 1 | Apr 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $5 → $4 | $3.02 | +32.45% | 6 | Jul 30, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Outperform | $183 → $203 | $254.29 | -20.17% | 2 | May 1, 2018 |
The Bank of New York Mellon Corporation
Mar 3, 2025
Maintains: Equal-Weight
Price Target: $86 → $96
Current: $86.56
Upside: +10.91%
AdaptHealth
Feb 13, 2025
Maintains: Buy
Price Target: $12 → $11
Current: $10.44
Upside: +5.36%
Enhabit
Nov 19, 2024
Reiterates: Market Perform
Price Target: $8.5 → $8
Current: $8.54
Upside: -6.32%
Regions Financial
Nov 15, 2024
Maintains: Equal-Weight
Price Target: $24 → $28
Current: $22.09
Upside: +26.75%
The PNC Financial Services Group
Nov 15, 2024
Maintains: Overweight
Price Target: $215 → $235
Current: $180.47
Upside: +30.22%
Fifth Third Bancorp
Nov 15, 2024
Maintains: Overweight
Price Target: $52 → $54
Current: $40.45
Upside: +33.50%
Bank of America
Nov 15, 2024
Maintains: Overweight
Price Target: $52 → $56
Current: $42.29
Upside: +32.42%
Morgan Stanley
Nov 15, 2024
Upgrades: Equal-Weight
Price Target: $107 → $142
Current: $123.75
Upside: +14.75%
Ardent Health Partners
Nov 12, 2024
Maintains: Outperform
Price Target: $23 → $25
Current: $15.32
Upside: +63.19%
Humana
Oct 2, 2024
Downgrades: Market Perform
Price Target: $400 → $250
Current: $262.12
Upside: -4.62%
Jul 10, 2024
Initiates: Outperform
Price Target: $100
Current: $100.00
Upside: -
May 14, 2024
Downgrades: Market Perform
Price Target: $5
Current: $4.02
Upside: +24.38%
Feb 20, 2024
Initiates: Outperform
Price Target: $15
Current: $18.39
Upside: -18.43%
Dec 14, 2023
Maintains: Underweight
Price Target: $45 → $52
Current: $59.38
Upside: -12.43%
Aug 23, 2023
Maintains: Overweight
Price Target: $60 → $55
Current: $72.96
Upside: -24.62%
Jun 14, 2023
Maintains: Outperform
Price Target: $625 → $560
Current: $475.98
Upside: +17.65%
May 26, 2023
Upgrades: Outperform
Price Target: n/a
Current: $177.72
Upside: -
Apr 3, 2023
Maintains: Equal-Weight
Price Target: $50 → $38
Current: $51.28
Upside: -25.90%
Apr 3, 2023
Maintains: Overweight
Price Target: $420 → $390
Current: $593.07
Upside: -34.24%
Apr 3, 2023
Maintains: Overweight
Price Target: $98 → $97
Current: $92.54
Upside: +4.82%
Apr 3, 2023
Maintains: Equal-Weight
Price Target: $165 → $155
Current: $178.20
Upside: -13.02%
Apr 3, 2023
Maintains: Overweight
Price Target: $21 → $20
Current: $16.26
Upside: +23.00%
Feb 8, 2023
Maintains: Market Perform
Price Target: $309 → $335
Current: $309.83
Upside: +8.12%
Jan 26, 2023
Reiterates: Outperform
Price Target: $580
Current: $397.47
Upside: +45.92%
Jan 5, 2023
Maintains: Market Perform
Price Target: $96 → $85
Current: $92.03
Upside: -7.64%
Dec 16, 2022
Maintains: Outperform
Price Target: $238 → $286
Current: $319.63
Upside: -10.52%
Nov 22, 2022
Maintains: Outperform
Price Target: $55 → $40
Current: $23.97
Upside: +66.88%
Nov 11, 2022
Maintains: Outperform
Price Target: $46 → $39
Current: $25.69
Upside: +51.81%
Nov 8, 2022
Maintains: Market Perform
Price Target: $3 → $1.5
Current: $3.83
Upside: -60.84%
Nov 4, 2022
Maintains: Outperform
Price Target: $33 → $30
Current: $3.54
Upside: +747.46%
Nov 4, 2022
Maintains: Market Perform
Price Target: $20 → $16
Current: $14.59
Upside: +9.66%
Oct 25, 2022
Maintains: Outperform
Price Target: $89 → $55
Current: $126.02
Upside: -56.36%
Aug 26, 2022
Maintains: Outperform
Price Target: $95 → $103
Current: $29.68
Upside: +247.04%
Apr 4, 2022
Maintains: Overweight
Price Target: $235 → $175
Current: $116.31
Upside: +50.46%
Apr 4, 2022
Initiates: Outperform
Price Target: $19
Current: $15.81
Upside: +20.18%
Jul 30, 2018
Maintains: Neutral
Price Target: $5 → $4
Current: $3.02
Upside: +32.45%
May 1, 2018
Assumes: Outperform
Price Target: $183 → $203
Current: $254.29
Upside: -20.17%